Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
Schellenberg D, Gabos Z, Duimering A, Debenham B, Fairchild A, Huang F, Rowe LS, Severin D, Giuliani ME, Bezjak A, Lok BH, Raman S, Chung P, Zhao Y, Ho CK, Lock M, Louie AV, Lefresne S, Carolan H, Liu M, Yau V, Ye A, Olson RA, Mou B, Mohamed IG, Petrik DW, Dosani M, Pai H, Valev B, Gaede S, Warner A, Palma DA.
Schellenberg D, et al. Among authors: duimering a.
Int J Radiat Oncol Biol Phys. 2024 Aug 19:S0360-3016(24)03281-4. doi: 10.1016/j.ijrobp.2024.08.031. Online ahead of print.
Int J Radiat Oncol Biol Phys. 2024.
PMID: 39168356